ATE363910T1 - Behandlung von krebserkrankungen durch aplidin - Google Patents

Behandlung von krebserkrankungen durch aplidin

Info

Publication number
ATE363910T1
ATE363910T1 AT00976137T AT00976137T ATE363910T1 AT E363910 T1 ATE363910 T1 AT E363910T1 AT 00976137 T AT00976137 T AT 00976137T AT 00976137 T AT00976137 T AT 00976137T AT E363910 T1 ATE363910 T1 AT E363910T1
Authority
AT
Austria
Prior art keywords
aplidine
treatment
cancer diseases
tumor
complementing
Prior art date
Application number
AT00976137T
Other languages
English (en)
Inventor
Glynn Thomas Faircloth
Chris Twelves
Luis Paz-Ares
Original Assignee
Pharma Mar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9927006.8A external-priority patent/GB9927006D0/en
Priority claimed from GB0005701A external-priority patent/GB0005701D0/en
Priority claimed from GB0007639A external-priority patent/GB0007639D0/en
Priority claimed from GB0015496A external-priority patent/GB0015496D0/en
Priority claimed from GB0025209A external-priority patent/GB0025209D0/en
Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa
Application granted granted Critical
Publication of ATE363910T1 publication Critical patent/ATE363910T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00976137T 1999-11-15 2000-11-15 Behandlung von krebserkrankungen durch aplidin ATE363910T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9927006.8A GB9927006D0 (en) 1999-11-15 1999-11-15 Aplidine treatment of cancers
GB0005701A GB0005701D0 (en) 2000-03-09 2000-03-09 Antitumor utility of aplidine
GB0007639A GB0007639D0 (en) 2000-03-29 2000-03-29 Antitumour and anti-angiogenic compound
GB0015496A GB0015496D0 (en) 2000-06-23 2000-06-23 Antitumour and anti-angiogenic compound
GB0025209A GB0025209D0 (en) 2000-10-13 2000-10-13 Treatment of cancers

Publications (1)

Publication Number Publication Date
ATE363910T1 true ATE363910T1 (de) 2007-06-15

Family

ID=27515929

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00976137T ATE363910T1 (de) 1999-11-15 2000-11-15 Behandlung von krebserkrankungen durch aplidin

Country Status (27)

Country Link
US (1) US20090298752A1 (de)
EP (1) EP1229922B1 (de)
JP (1) JP2003514025A (de)
KR (1) KR100518986B1 (de)
CN (1) CN1423564A (de)
AT (1) ATE363910T1 (de)
AU (1) AU780417B2 (de)
BG (1) BG65381B1 (de)
BR (1) BR0015811A (de)
CA (1) CA2391502A1 (de)
CY (1) CY1106825T1 (de)
CZ (1) CZ302498B6 (de)
DE (1) DE60035120T2 (de)
DK (1) DK1229922T3 (de)
ES (1) ES2288486T3 (de)
HK (1) HK1045648B (de)
HU (1) HUP0203906A2 (de)
IL (1) IL149488A0 (de)
MX (1) MXPA02004862A (de)
NO (1) NO330719B1 (de)
NZ (1) NZ518847A (de)
PL (1) PL200922B1 (de)
PT (1) PT1229922E (de)
RU (1) RU2261104C2 (de)
SI (1) SI1229922T1 (de)
SK (1) SK287762B6 (de)
WO (1) WO2001035974A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030148933A1 (en) 1990-10-01 2003-08-07 Pharma Mar S.A. Derivatives of dehydrodidemnin B
GB9803448D0 (en) 1998-02-18 1998-04-15 Pharma Mar Sa Pharmaceutical formulation
UA76718C2 (uk) 2000-06-30 2006-09-15 Фарма Мар, С.А. Протипухлинні похідні аплідину
CZ2003993A3 (cs) 2000-10-12 2004-02-18 Pharma Mar, S. A. Léčivo pro léčení rakoviny podáváním aplidinu nebo analogu aplidinu a protektoru kosterního svalstva
US20050004012A1 (en) * 2001-10-19 2005-01-06 Ramon Mangues Use of aplidine for the treatment of pancreatic cancer
EP1603584B1 (de) * 2003-03-12 2008-08-27 Dana-Farber Cancer Institute, Inc. Aplidine zur behandlung von multiplem myelom
JP2006519848A (ja) * 2003-03-12 2006-08-31 ファルマ・マール・ソシエダード・アノニマ 改良された抗腫瘍治療
KR101512503B1 (ko) * 2006-02-28 2015-04-15 파르마 마르 에스.에이. 개선된 항종양 치료
JP5547487B2 (ja) * 2006-11-03 2014-07-16 ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ 抗癌化合物の投与方法
JP2011500650A (ja) * 2007-10-19 2011-01-06 ファルマ・マール・ソシエダード・アノニマ 改良された抗腫瘍治療
JP2011513429A (ja) * 2008-03-07 2011-04-28 ファルマ・マール・ソシエダード・アノニマ 改善された抗癌治療法
CN103463020B (zh) * 2013-09-23 2015-11-25 李淑兰 Lycojaponicumin A在制备治疗肾癌药物中的应用
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4342744A (en) * 1979-07-19 1982-08-03 Lever Brothers Company Hair treatment products
US4950649A (en) * 1980-09-12 1990-08-21 University Of Illinois Didemnins and nordidemnins
US4493796A (en) * 1980-09-12 1985-01-15 Board Of Trustees, Univ. Of Ill. Didemnins A, B, C, and derivatives thereof, as antiviral agents
DE3161556D1 (en) * 1980-09-12 1984-01-05 Univ Illinois Novel antibiotics, derivatives thereof, processes for their extraction, and compositions containing them
IT1153974B (it) * 1982-09-23 1987-01-21 Erba Farmitalia Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento
DE3684868D1 (de) * 1985-09-20 1992-05-21 Cernitin Sa Verwendung von pflanzenpollenextrakten zur herstellung von das wachstum von tumorzellen hemmenden pharmazeutischen praeparaten und verfahren zu ihrer herstellung.
US20030148933A1 (en) * 1990-10-01 2003-08-07 Pharma Mar S.A. Derivatives of dehydrodidemnin B
GB8922026D0 (en) * 1989-09-29 1989-11-15 Pharma Mar Sa Novel anti-viral and cytotoxic agent
US5580871A (en) * 1992-11-20 1996-12-03 The Dupont Merck Pharmaceutical Company 4-Heteroaryl- 1,4-dihydropyridine compounds with calcium agonist and alpha1 -antagonist activity
FR2698543B1 (fr) * 1992-12-02 1994-12-30 Rhone Poulenc Rorer Sa Nouvelles compositions à base de taxoides.
US5462726A (en) * 1993-12-17 1995-10-31 Bristol-Myers Squibb Company Method of inhibiting side effects of solvents containing ricinoleic acid or castor oil or derivatives thereof employing a thromboxane A2 receptor antagonist and pharmaceutical compositions containing such solvents
DE69431071T2 (de) * 1993-12-29 2003-03-20 Matrix Pharma Zusammensetzung für lokale freigabe von zytostatika
US5861439A (en) * 1994-11-14 1999-01-19 Alza Corporation Method for enhanced electrotransport agent delivery
US6365597B1 (en) * 1996-02-14 2002-04-02 Aventis Pharmaceuticals Inc. 4-aza steroids
DK0914116T3 (da) * 1996-05-22 2000-11-20 Protarga Inc Kompositstoffer omfattende konjugater af cis-docosahexaensyre og Taxotere
US6156724A (en) * 1996-06-07 2000-12-05 Rinehart; Kenneth L. Uses of didemnins as immunomodulating agents
US6034058A (en) * 1997-04-15 2000-03-07 Rinehart; Kenneth L. Semi-synthetic alanyl dilemnin analogs
EP0981352B8 (de) * 1997-05-07 2009-06-17 Pharma Mar, S.A. Verwendung von Aplidine zur Behandlung von kardiovaskulären Erkrankungen
US6245759B1 (en) * 1999-03-11 2001-06-12 Merck & Co., Inc. Tyrosine kinase inhibitors
US20010021380A1 (en) * 1999-04-19 2001-09-13 Pluenneke John D. Soluble tumor necrosis factor receptor treatment of medical disorders
US6890904B1 (en) * 1999-05-25 2005-05-10 Point Therapeutics, Inc. Anti-tumor agents
US6509315B1 (en) * 2000-04-07 2003-01-21 The Trustees Of The University Of Pennsylvania Didemnin analogs and fragments and methods of making and using them
NZ521844A (en) * 2000-04-07 2004-07-30 Univ Pennsylvania Tamandarin and didemnin analogs having deoxo-proline residue or dehydro-proline residue and methods of making and use thereof
UA76718C2 (uk) * 2000-06-30 2006-09-15 Фарма Мар, С.А. Протипухлинні похідні аплідину
CA2423462A1 (en) * 2000-10-05 2002-04-11 Immunex Corporation Nectin polypeptides, polynucleotides, methods of making and use thereof
CZ2003993A3 (cs) * 2000-10-12 2004-02-18 Pharma Mar, S. A. Léčivo pro léčení rakoviny podáváním aplidinu nebo analogu aplidinu a protektoru kosterního svalstva
AU2002224417A1 (en) * 2000-10-18 2002-04-29 Immunex Corporation Methods for treating il-18 mediated disorders
US6610399B1 (en) * 2000-11-17 2003-08-26 Structural Technologies, Llc Multi-layer, thermal protection and corrosion protection coating system for metallic tendons, especially for external post-tensioning systems
US20050004012A1 (en) * 2001-10-19 2005-01-06 Ramon Mangues Use of aplidine for the treatment of pancreatic cancer
EP1603584B1 (de) * 2003-03-12 2008-08-27 Dana-Farber Cancer Institute, Inc. Aplidine zur behandlung von multiplem myelom
JP2006519848A (ja) * 2003-03-12 2006-08-31 ファルマ・マール・ソシエダード・アノニマ 改良された抗腫瘍治療
MXPA05010064A (es) * 2003-03-21 2006-05-17 Madeleine M Joullie Analogos de tamandarin y fragmentos de los mismos y metodos para hacerlos y usarlos.
US20060019256A1 (en) * 2003-06-09 2006-01-26 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
KR101512503B1 (ko) * 2006-02-28 2015-04-15 파르마 마르 에스.에이. 개선된 항종양 치료
JP2011500650A (ja) * 2007-10-19 2011-01-06 ファルマ・マール・ソシエダード・アノニマ 改良された抗腫瘍治療

Also Published As

Publication number Publication date
HK1045648B (zh) 2007-09-21
CZ20021697A3 (cs) 2003-02-12
DE60035120T2 (de) 2008-01-31
CZ302498B6 (cs) 2011-06-15
DK1229922T3 (da) 2007-10-08
PL355335A1 (en) 2004-04-19
CN1423564A (zh) 2003-06-11
ES2288486T3 (es) 2008-01-16
EP1229922A2 (de) 2002-08-14
WO2001035974A2 (en) 2001-05-25
JP2003514025A (ja) 2003-04-15
PT1229922E (pt) 2007-09-12
NO20022293D0 (no) 2002-05-14
BG65381B1 (bg) 2008-05-30
SK287762B6 (sk) 2011-09-05
KR100518986B1 (ko) 2005-10-06
NZ518847A (en) 2004-02-27
BG106714A (en) 2003-02-28
SI1229922T1 (sl) 2008-04-30
PL200922B1 (pl) 2009-02-27
US20090298752A1 (en) 2009-12-03
HUP0203906A2 (en) 2003-03-28
NO20022293L (no) 2002-07-05
RU2002115864A (ru) 2004-01-20
WO2001035974A3 (en) 2001-11-01
RU2261104C2 (ru) 2005-09-27
AU780417B2 (en) 2005-03-17
HK1045648A1 (en) 2002-12-06
CY1106825T1 (el) 2012-05-23
SK6592002A3 (en) 2003-08-05
NO330719B1 (no) 2011-06-20
BR0015811A (pt) 2002-08-06
CA2391502A1 (en) 2001-05-25
KR20020064313A (ko) 2002-08-07
DE60035120D1 (de) 2007-07-19
AU1402301A (en) 2001-05-30
IL149488A0 (en) 2002-11-10
MXPA02004862A (es) 2003-01-28
EP1229922B1 (de) 2007-06-06

Similar Documents

Publication Publication Date Title
ATE363910T1 (de) Behandlung von krebserkrankungen durch aplidin
DE69840006D1 (de) Pharmazeutische Zusammensetzungen enthaltend Arsentrioxid zur Behandlung von multiplen Myelom
DE3689363D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung der Metastasen von Krebstumoren.
YU69903A (sh) Postupak i dozni oblik za lečenje tumora primenom tegafura, uracila, folne kiseline, paklitaksela i karboplatina
DK0767786T3 (da) 7-ether-taxol-analoge, antineoplastisk anvendelse deraf og farmaceutiske præparater indeholdende disse forbindelser
DE60141194D1 (de) Behandlung des metastasierenden Karzinoms der Niere
WO2002046416A3 (en) Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
WO2000061756A3 (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
WO2000063219A8 (en) Platinum complexes for the treatment of cancer
FI1496918T3 (fi) Natriummeta-arseniitin käyttö kasvainten hoidossa
ATE293991T1 (de) VERWENDUNG EINES MIT DEM PEPTID ßELAGIGILTVß ASSOZIIERTEN ENTEROBAKTERIEN-PROTEINS OMPA ZUR BEHANDLUNG VON MELANOMEN
ATE329597T1 (de) Die verwendung von einer 4- pyridylmethylphtalazine enthaltenden kombination zur behandlung von tumoren
AU5302599A (en) Method for diagnosing bone metastasis of malignant tumor
WO2004098651A3 (en) Bone localising radiopharmaceutical and tubulin-interacting compound combinatorial radiotherapy
MXPA04002407A (es) Uso de 4-piridilmeetil-ftalazinas para el tratamiento de cancer.
UA30391A (uk) Спосіб лікування колоректального раку
WO2004004756A8 (fr) UTILISATION D'ANTAGONISTES DE LA PTHrP POUR TRAITER LE CARCINOME A CELLULES RENALES
RU99103901A (ru) Способ медикаментозного лечения злокачественных опухолей
MX9605355A (es) El uso de antagonistas de receptor nk-1 para preparar composiciones para tratar cancer.
ATE312610T1 (de) Liposomale formulierungen von phenylalanin- derivaten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1229922

Country of ref document: EP